health
By Toby Sterling and Richard Lough
AMSTERDAM, May 6 (Reuters) – It was billed as an Atlantic odyssey to some of the most remote islands in the world. Instead, the cruise on the hantavirus-stricken MV Hondius was left stranded off Cape Verde with passengers in their cabins, medics in protective suits tending to...
Read More
Promising Revolution Medicines pancreatic cancer drug has high rate of mostly manageable side effectsÂ
By Nancy Lapid
May 6 (Reuters) – An experimental drug from Revolution Medicines that nearly doubled survival time for patients with advanced pancreas cancer in clinical trials comes with a high rate of mostly low-grade side effects, researchers reported on Wednesday.
The...
Read More
The Media Line: With Trauma Cases Climbing, Why Is Israel Questioning Medical Cannabis Now?
With Trauma Cases Climbing, Why Is Israel Questioning Medical Cannabis Now?
The number of people using medical cannabis in Israel is higher than ever, but growing evidence suggests that medical cannabis not only does not necessarily treat PTSD but may actually worsen it
By...
Read More
health Headlines
Argentina’s hot spot for Antarctic cruises insists it didn’t cause the hantavirus outbreak- US FDA to ease crackdown on some under-review unauthorized vapes
- US FDA approves Partner Therapeutics’ bile duct cancer drug under fast-track review
- Argentine authorities say hantavirus patients not likely infected in Tierra del Fuego province
- Trump plans to fire US FDA chief Makary, sources say
- The Latest: Stricken cruise ship heads for the Canaries as authorities rush to identify contacts
- What we don’t know about the hantavirus outbreak as the cruise ship nears Spanish territory
- Biotech firm Odyssey hits nearly $900 million valuation as shares rise in Nasdaq debut
- Exclusive-Kennedy’s health officials explored US ban of some widely used antidepressants, sources say
- Molina bets on medical cost control for fivefold profit jump by 2029
- California to provide free diapers to newborns at more than 60 hospitals
- Factbox-How does Spain plan to evacuate passengers from the hantavirus-hit cruise ship?
- Factbox-What to know about Tristan da Cunha, the island with a suspected hantavirus case
- Hantavirus cruise ship part of Antarctic tourism boom that some want better regulated
- Experts race to write guidance to contain first ship-borne hantavirus outbreak
- Lilly’s obesity pill tops 7,000 prescriptions in fourth week, signals modest uptake
- Spain tests suspected hantavirus case in Alicante
- Somalia faces severe malnutrition crisis as WFP warns of aid halt
- Researchers identify antibodies that may prevent and treat measles infections
- Spain readies for evacuations as a hantavirus-hit cruise ship heads for the Canary Islands
- Two suspected hantavirus cases found in Spain, remote Tristan da Cunha
- KLM flight attendant tested negative for hantavirus infection, WHO says
- UK says third British national has suspected hantavirus
- US lifts hold on immigration applications for doctors, but leaves others waiting
- US CDC classifies hantavirus outbreak as ‘level 3’ emergency response, ABC News reports
- Singapore tests two residents for hantavirus after cruise outbreak
- Biotech firm Odyssey raises $279 million in upsized US IPO
- McKesson expects 2027 profit slightly above estimates on drug distribution strength
- US FDA issues recall of Boston Scientific heart devices
- A timeline of the cruise ship hantavirus outbreak and when passengers fell sick
- Gilead raises 2026 sales forecast, flags profit hit from acquisitions
- Injured US military veterans find relief and awe swimming with a whale shark at Georgia Aquarium
- Agency will move forward with plans to propose weakening some Biden-era PFAS limits, official says
- US CDC notifies Texas of two state residents on cruise ship with hantavirus outbreak
- Viatris beats quarterly estimates on China strength, branded drug sales
- FDA’s new playbook: Lots of media announcements but not much rulemaking
- Analysis-Novo and Lilly gain on signs weight-loss pills could expand the market
- Becton Dickinson raises 2026 profit forecast on drug delivery devices demand
- Charles River beats quarterly estimates on steady demand for drug development services
- Kenvue beats first-quarter estimates amid pending acquisition by Kimberly-Clark
- Entrada shares sink after Duchenne drug falls short of expectations
- Countries track passengers of virus-hit cruise ship
- Italy’s Angelini to buy US Catalyst Pharma in $4.1 billion state-backed deal
- Global crackdown on illicit pharmaceuticals sees $15.5 million in seizures
- Fake rumors, real killings: Inside Congo’s deadly health misinformation crisis
- Switzerland’s Roche agrees to acquire US-based PathAI
- Zealand unveils buyback, Roche payments; shares rise
- Siemens Healthineers cuts 2026 outlook on Chinese market woes
- Moderna’s mRNA flu vaccine outperforms standard shot in late-stage trial
- Argentina to test rodents at origin point of hantavirus-hit cruise ship
